WENDY GILL: Open Payments
NPI 1821272709 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,766 in 110 payments from 34 companies in 2025. Trend: 2023 $2,809 · 2024 $2,414 · 2025 $2,766
Food & beverage: $2,483Education: $283
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $657 |
| PFIZER INC. | 14 | $275 |
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| ABBVIE INC. | 6 | $136 |
| Geron Corporation | 4 | $99 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Astellas Pharma US Inc | 4 | $91 |
| SEAGEN INC. | 1 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
Products named: RYBREVANT, DARZALEX, XTANDI, RYTELO, KISQALI, NINLARO, KEYTRUDA, IBRANCE.
Industry payments across LA — which companies pay providers there.
